News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Teva Pharmaceutical Industries Limited Introduces First Generic Lamictal(R) Tablets in the United States
July 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has commenced commercial shipment of its generic version of Lamictal® (Lamotrigine) Tablets, 25mg, 100 mg, 150 mg, and 200 mg.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Lung cancer
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
September 14, 2026
·
4 min read
·
Gabrielle Masson
China
Beyond China: Five other overseas destinations for biopharma dollars
September 9, 2026
·
8 min read
·
Tristan Manalac
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
·
5 min read
·
Angela Gabriel
Startups
10 life sciences startups selected for accelerator program
September 4, 2026
·
2 min read
·
Angela Gabriel